Skip to content

Obstetric analgesia: a comparison of patient controlled Pethidine, Remifentanil and Fentanyl in labour.

Obstetric analgesia: a comparison of patient controlled pethidine, remifentanil and fentanyl in labour.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29457
Enrollment
180
Registered
2005-12-04
Start date
2005-08-10
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labourpain

Interventions

The following drugs are used in a patient controlled method: 1. Pethidine
2. Remifentanil
3. Fentanyl. Medication will be started in active labour en will be continued untill complete dilation of the cervix is achieved.

Sponsors

Bronovo hospital, Department of Obstetrics and Gynaecology, The Hague
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: at least 18 years old; 2. Between 37 and 42 weeks of gestation; 3. ASA physical status I or II.

Exclusion criteria

Exclusion criteria: 1. ASA physical status >= III; 2. Obesity (BMI equal or more than 40 kg/m2); 3. Substance abuse history; 4. High risk patients: including pre-eclampsia (diastolic pressure equal or more than 100, proteinuria), hepatic insufficiency or renal failure, severe asthma, poorly controlled diabetes mellitus); 5. Premature labour; 6. Drug allergy; history of hypersensitivity to opioid substances.

Design outcomes

Primary

MeasureTime frame
1. Quality of pain relief determined by Visual Analogue Scale, PCA demands/rewards and the number of parturients crossing over to epidural analgesia; 2. Patient satisfaction; 3. Fetal Outcome as determined by Apgar, NACS and requirement for naloxone; 4. Presence of opioid substances in umbilical and maternal blood samples.

Contacts

Public ContactM.R. Douma

Leiden University Medical Center Department of Anesthesiology P.O. Box 9600

maritdouma@hotmail.com0031 (0)6 14276591

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)